1-11 of 11
Authors: Mark A Socinski
Sort by
Journal Article
Emerging molecular testing paradigms in non-small cell lung cancer management—current perspectives and recommendations
Frédérique Penault-Llorca and Mark A Socinski
The Oncologist, Volume 30, Issue 3, March 2025, oyae357, https://doi.org/10.1093/oncolo/oyae357
Published: 24 March 2025
Journal Article
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials
Lee X Li and others
The Oncologist, Volume 28, Issue 4, April 2023, Pages e205–e211, https://doi.org/10.1093/oncolo/oyad043
Published: 11 March 2023
Journal Article
Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non‐Small Cell Lung Cancer
Mohammad Jahanzeb and others
The Oncologist, Volume 25, Issue 10, October 2020, Pages 867–877, https://doi.org/10.1634/theoncologist.2020-0011
Published: 23 July 2020
Journal Article
Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non‐Small Cell Lung Cancer and the Role of Biopsy at Progression
Mark A. Socinski and others
The Oncologist, Volume 22, Issue 1, January 2017, Pages 3–11, https://doi.org/10.1634/theoncologist.2016-0285
Published: 17 January 2017
Journal Article
A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer
Juneko E. Grilley-Olson and others
The Oncologist, Volume 20, Issue 2, February 2015, Pages 105–106, https://doi.org/10.1634/theoncologist.2014-0327
Published: 23 January 2015
Journal Article
Reinforcement Learning Strategies for Clinical Trials in Nonsmall Cell Lung Cancer
Get access
Yufan Zhao and others
in
Biometrics
Biometrics, Volume 67, Issue 4, December 2011, Pages 1422–1433, https://doi.org/10.1111/j.1541-0420.2011.01572.x
Published: 08 March 2011
Journal Article
Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?
Thomas E. Stinchcombe and Mark A. Socinski
The Oncologist, Volume 13, Issue 9, September 2008, Pages 933–944, https://doi.org/10.1634/theoncologist.2008-0019
Published: 02 September 2008
Journal Article
Considerations for Second-Line Therapy of Non-Small Cell Lung Cancer
Thomas E. Stinchcombe and Mark A. Socinski
The Oncologist, Volume 13, Issue S1, January 2008, Pages 28–36, https://doi.org/10.1634/theoncologist.13-S1-28
Published: 01 January 2008
Journal Article
Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer
Thomas E. Stinchcombe and others
The Oncologist, Volume 11, Issue 7, July 2006, Pages 809–823, https://doi.org/10.1634/theoncologist.11-7-809
Published: 01 July 2006
Journal Article
Single-Agent Paclitaxel in the Treatment of Advanced Non-Small Cell Lung Cancer
Mark A. Socinski
The Oncologist, Volume 4, Issue 5, October 1999, Pages 408–416, https://doi.org/10.1634/theoncologist.4-5-408
Published: 01 October 1999
Journal Article
Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know
Suzanne George and others
The Oncologist, Volume 3, Issue 1, February 1998, Pages 35–44, https://doi.org/10.1634/theoncologist.3-1-35
Published: 01 February 1998
Advertisement
Advertisement